Latest News
Commonfund Capital has held the closing of its third global private equity fund, Commonfund Capital Global Private Equity Partners III at USD236.6 million, above its prior global fund that closed at USD228.8 million.
The fund had strong participation from existing limited partners as well as a number of new investors; limited partners included pensions, foundations, endowments, insurance companies, family offices and sophisticated clients of registered investment advisors and consultants.
Commonfund Capital has been investing in private equity since 1988 and specialises in smaller and medium sized funds and managers that are sector and geographic specialists, many of which are
CGE Partners (CGE) has invested in ethiXbase, a provider of third-party risk assessment services to corporates, focusing on anti-corruption, human rights, labour, and the environment.
CGE is partnering with Leas Bachatene (CEO), Russell Potter (CFO) and Michelle Knight (Head of Operations) to back the company in its next phase of growth to become the leading global provider of supply chain risk assessment software solutions. CGE will bring significant experience and resource to support ethiXbase’s international expansion, future M&A and new product development initiatives.
Leas Bachatene, CEO of ethiXbase, comments: “ethiXbase’s mission to support organisations worldwide to adopt sustainable and socially
AUA Private Equity Partners portfolio company Westminster Pet Products, has acquired substantially all of the assets of Pet Ventures, dba Pet ‘n Shape.
Established in 2005 by the Abramson Family, Pet ‘n Shape is an emerging brand of pet treats and chews that offers a full-line of branded, high-quality products made from natural ingredients.
Joe Flanigan, CEO of Westminster, says: “The combination of Westminster and Pet ‘n Shape allows us to build on the success Pet ‘n Shape has established in the online and e-commerce channels, and enables us to serve a larger customer base, across new channels, with a
Biotech company Anjarium Biosciences (Anjarium) has closed a CHF55.5 million (USD61 million) Series A financing, co-led by Abingworth and Gimv, with significant participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company).
Anjarium’s innovative approach leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted gene therapies, optimised to improve patient outcomes in a range of serious genetic diseases.
The Company’s unique platform combines proprietary DNA-based gene vectors, natural and synthetic nanoparticle delivery modalities – including its novel Hybridosome technology – and cost-efficient, scalable manufacturing solutions.
In accordance with a shareholders’ agreement entered into on 10 August 2020, Amber Capital (on behalf of the funds it manages) has informed Vivendi of its intention to sell all of its Lagardère shares to enable Vivendi to exercise, as the case may be, its right of first offer in accordance with the agreement.
In this context, Vivendi made an offer to purchase the 25,305,448 Lagardère shares held by Amber Capital, representing 17.93 per cent of the share capital and 14.34 per cent of the theoretical voting rights of Lagardère, at a price per share of EUR24.10.
This proposal
Tikehau Capital, the global alternative asset management group, has arranged a HoldCo PIK financing to support CVC Capital Partners Fund VIII (“CVC”) and BIP equity partners in its investment in BIP, a management consulting company specialised in digital transformation and innovation.
Founded in Italy in 2003, BIP is a leading international consulting firm present in 13 countries, with more than 3,500 employees and a turnover of EUR315 million in 2020 (31 per cent increase vs 2019).
Tikehau Capital has been backing BIP’s remarkable growth since 2018, supporting the company doubling its revenues and expanding internationally.
Tikehau Capital was advised by
Synechron Inc, a digital transformation consulting firm focused exclusively on the financial services industry, has formed a partnership with Accelex Technology to further drive operational efficiencies for its financial services clients.
Accelex offers an advanced artificial intelligence (AI) and machine learning-led automation system for effective data acquisition, analytics and reporting that can afford tangible benefits to investors and asset servicers.
Synechron has been working with Accelex since 2018 and has successfully leveraged the firm’s innovative AI and machine learning models – based solutions for the trifecta of key data management: data acquisition, analytics, and visual display reporting for clients.
Clients of Connection Capital, the specialist private client investment business, have collectively invested GBP5 million into HP Access Fund II, a specialist venture capital (VC) fund focused on buying secondary stakes in later stage investments in the UK and European technology companies.
HIG WhiteHorse, a credit affiliate of global investment firm HIG Capital (“HIG”), has arranged a refinancing package for Kermel (the “Company”), which also includes a growth capital component.
Kermel is a technical fibre manufacturer for flame and heat resistant clothing. The Company manufactures polyamide-imide fibres for garments dedicated to personal protection that demonstrate exceptional resistance to heat, fire and abrasion in extreme circumstances.
HIG WhiteHorse has committed EUR73 million of unitranche and capex facilities to refinance the borrower’s existing indebtedness and provide additional capital to finance the Company’s growth. Kermel has plans to increase its production capacity in the coming
Nova Pangaea Technologies, a UK company which converts woody and agricultural residues into sustainable biocarbons, biofuels, biochemicals and biopolymers has raised a further GBP2.4 million from existing investors as part of a successful Series A funding round.
The latest investment has been led by Par Equity, alongside Northern Powerhouse Investment Fund (NPIF) and Cambridge Angels as well as several existing private investors. It is the largest fundraising round for the company and represents an enhanced valuation of the business.
Nova Pangaea’s continuous thermo-chemical process, called REFNOVA, converts feedstocks such as sustainable wood, straw and other crop residues into biocarbons,
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
